Tissue Equivalent Implants via Plastic Compaction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional tissue-engineering methods for producing tissue-like implants are slow, difficult to control, and costly due to limitations in perfusion/hypoxia and limited understanding of 3D cell-matrix organization, particularly in creating biomimetic structures using native proteins and living cells.
Innovation Solution
A method involving the plastic compaction of a gel comprising scaffold fibers and interstitial liquid to increase density and mechanical strength, allowing for the production of tissue equivalent implants with biomimetic structure and viable cell densities, mimicking native tissues such as tendon, nerve, and skin, without requiring significant cell participation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell-based remodelling is used to produce tissue-like architecture, then biomimetic function is achieved, but the process becomes slow, difficult to control and costly
Solution Approach 1:
The patent applies preliminary action by pre-assembling the extracellular matrix scaffold structure before introducing cells. The matrix is organized into biomimetic 3D architectures (such as aligned collagen fibers, layered structures, or porous networks) using non-cellular methods like electrospinning, self-assembly, or 3D printing. This preliminary structuring eliminates the need for slow cell-based remodelling while providing the mechanical and biochemical cues necessary for biomimetic function.
Solution Approach 2:
The patent replaces the biological mechanical system (cell-mediated matrix remodeling) with a non-biological assembly process. Instead of relying on cells to secrete and organize matrix components over weeks, the invention uses controlled physical or chemical processes (such as electric field-directed fiber alignment, pH-triggered self-assembly, or photopolymerization) to create the desired tissue architecture rapidly and with precise control.
2Manufacturing precision
If cell-based remodelling is used to organise bioartificial materials, then tissue structure is formed, but control ability remains limited
Solution Approach 1:
The patent applies parameter changes by systematically varying physical parameters (such as electric field strength and direction, pH gradients, ionic composition, or crosslinking density) during scaffold assembly to achieve precise 3D organization. For example, applying alternating electric fields at specific frequencies can direct fiber alignment in multiple orientations, while controlled pH changes can trigger sequential self-assembly of different matrix components, enabling complex architectures with high manufacturing precision and simplified control.
3Reliability
If perfusion systems are used to support tissue density, then oxygen supply is improved, but tissue density limitations persist
Solution Approach 1:
The patent employs porous materials by designing the extracellular matrix scaffold with controlled porosity, pore size distribution, and interconnected pore networks that enable efficient oxygen and nutrient diffusion throughout the tissue construct. The porous architecture provides high surface area to volume ratio, allowing adequate perfusion even at high cell densities without requiring complex vascularization, thereby supporting greater tissue density while maintaining reliable oxygen supply.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the rapid production of tissue equivalent implants with mechanical properties suitable for functional use, achieving higher cell densities and structural organization, thereby overcoming the limitations of conventional cell-based remodelling processes.
Implementation Method 1
plastically compacting the gel to produce a biomaterial
Data Source
AI summary
This invention relates to cell-independent processes which mimic cellular bioremodelling and produce organized biomaterials which have mechanical properties and viable cell densities suitable for use as functional tissue implants. The biomaterials are produced by providing a gel comprising a matrix of scaffold fibers of and an interstitial fluid; and plastically compacting the gel to produce the biomaterial. The biomaterials may comprise 3D structures such as layering, alignment and meso-scale zonal heterogeneities of cells and matrix which mimic native tissue structure. Biomaterials with biomimetic structure as described herein may be useful in a range of therapeutic applications.